§ BIOTECHNOLOGY
USD · BiotechnologyABVX
ABIVAX SA-ADR
USDSector · BiotechnologyBeta · 0.71
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
211 increased/new, 97 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 19.86 | EPS (TTM) | -5.53 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| TCG Crossover Management, LLC | 6.5M | 20.6% | −9% |
| UBS Group AG | 4.5M | 0.1% | +3% |
| Darwin Global Management, Ltd. | 3.5M | 9.3% | +9% |
| Morgan Stanley | 1.7M | 0.0% | n/a |
| Vestal Point Capital, LP | 1.5M | 4.7% | −21% |
| Caligan Partners LP | 1.5M | 10.8% | +1% |
◇ AC INTELLIGENCE
Top institutional owners for ABVX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER99.3% · 0 holders
OTHER0.5% · 193 holders
DEALER / BANK0.1% · 22 holders
QUALITY / COMPOUNDER0.1% · 13 holders
PASSIVE / INDEX0.0% · 7 holders
TACTICAL / MACRO0.0% · 6 holders
INCOME / DEFENSIVE0.0% · 5 holders
SYSTEMATIC / QUANT0.0% · 6 holders
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ABVX in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention ABVX yet.